治疗儿童多系统炎症综合征的治疗方法
Tong Tong1, Yi-Hua Jin1, Min Wang1
1Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, China.
World journal of pediatrics : WJP
|March 21, 2024
概括
儿童多系统炎症综合征 (MIS-C) 是一种严重的COVID-19并发症. 本综述系统地总结了最近的MIS-C治疗策略,强调了需要标准化方案和进一步研究的需要.
科学领域:
- 儿科重症监护医药 儿科重症监护医药
- 传染病 传染病 传染病
- 类风湿病学 类风湿病学
背景情况:
- 儿童多系统炎症综合征 (MIS-C) 是一种严重但不常见的儿科并发症,与COVID-19有关.
- 目前对MIS-C的管理策略包括静脉注射免疫球蛋白 (IVIG),葡萄皮质激素 (GC),生物药物 (例如,anakinra,infliximab) 和抗凝固药物治疗.
- 尽管有各种方法,但缺乏成熟的治疗系统,许多方面仍在争论中.
研究的目的:
- 系统地审查和总结COVID-19相关的MIS-C治疗的最新进展.
- 根据最新的文献,提供当前治疗策略的全面概述.
主要方法:
- 在PubMed/Medline,科学网,EMBASE和Cochrane图书馆进行了文献搜索,截至2023年9月20日.
- 关键词包括"多系统炎症综合征"",MIS-C"",PIMS-TS"",治疗"",治疗"",药物"",IVIG"",GCs"",静脉免疫球蛋白"",皮质类固醇"",生物剂"和"阿司匹林".
主要成果:
- MIS-C的严重程度表现出显著的变化,需要量身定制的治疗方案.
- 最近的文献提供了关于管理这种异质状况的最新见解.
结论:
- MIS-C是一种复杂的多系统性疾病,具有相当大的异质性.
- 增强的临床经验为治疗提供了新的视角,但协议的标准化和严格的研究至关重要.
- 进一步的研究是必不可少的,以加深对MIS-C的理解和优化管理策略.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
01:29Drugs for Treatment of Ulcerative Colitis in IBD
139
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
139
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331